ロード中...
Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B‐cell‐targeted therapies
Multiple sclerosis (MS) is a chronic inflammatory disease of the CNS, and one of the most common causes of disability in young adults. Over the last decade, new disease‐modifying therapies have emerged, including monoclonal antibodies (mAbs) that provide highly targeted therapies with greater effica...
保存先:
| 出版年: | Br J Pharmacol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5466523/ https://ncbi.nlm.nih.gov/pubmed/28319650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13780 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|